ArticleBMC infectious diseases2020

A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol.

Sergio Fragoso-Saavedra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.